Luye Pharma Group Ltd.
Clinical trials sponsored by Luye Pharma Group Ltd., explained in plain language.
-
New hope for Tough-to-Treat colon cancer
Disease control Not yet recruitingThis study is testing a new oral drug, LPM6690176, to see if it is safe and effective when added to standard chemotherapy for people with advanced colorectal cancer that has spread and has a specific genetic change (RAS mutation). The first part of the study will find the safest …
Phase: PHASE1, PHASE2 • Sponsor: Luye Pharma Group Ltd. • Aim: Disease control
Last updated Mar 30, 2026 14:33 UTC
-
New pill tested to calm severe schizophrenia episodes
Disease control Not yet recruitingThis study is testing a new extended-release tablet called LY03020 for adults experiencing an acute worsening of schizophrenia symptoms. It will compare the drug to a placebo (inactive pill) to see if it better reduces symptoms like hallucinations and delusions and is safe. The g…
Phase: PHASE2 • Sponsor: Luye Pharma Group Ltd. • Aim: Disease control
Last updated Mar 27, 2026 12:38 UTC